Source: International Congress 2015 – Immune mechanisms in the human lung
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Jing Yang (Beijing, China), Jing Yang, Michael Humphries, Shuang Ren, Linda Wang, Abhijit Pethe, Ioannis Kottakis. Evaluation of omalizumab therapy in a Chinese versus predominantly Caucasian population: Comparison of clinical data. Eur Respir J 2015; 46: Suppl. 59, 4038

Member's Comments

No comment yet.

Related content which might interest you: Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Effect of an individualized education program on asthma control and health-related quality of life in adult asthma patients: A prospective study Source: International Congress 2016 – Abstracts in medical education, the web and the internet Year: 2016 Quality of life and asthma control in elderly asthmatics: A seven year follow-up – Results from the PRAXIS study Source: International Congress 2016 – Asthma management in primary care Year: 2016 The control of asthma in real life: Baseline evaluation of a long-term study Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Effectiveness of omalizumab in Greek patients with severe allergic asthma (SAA): The SMILE study Source: International Congress 2016 – Asthma points to ponder Year: 2016 One year dynamics of life quality depending on the adherence to therapy in patients with bronchial asthma Source: Annual Congress 2013 –Asthma at the bedside Year: 2013 LATE-BREAKING ABSTRACT: Effectiveness of individualized self management support for children with asthma in Dutch outpatient clinics, preliminary results of a randomized controlled trial. Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Factors associated with patient perspective outcomes in a cohort of asthmatics Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Examination of variations in responder rates in COPD clinical trial outcomes Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Identification and validation of asthma phenotypes in Chinese population using cluster analysis Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 X-Tab: Non-interventional study to assess patient-related mid-term outcomes of omalizumab therapy in severe allergic asthmatic patients Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Fluticasone propionate/formoterol therapy for asthmatic patients: Results of a non-interventional study Source: International Congress 2016 – Asthma management Year: 2016 The German Severe Asthma Registry: FeNO values correlate with medical therapy, quality of life and smoking Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Bronchial thermoplasty in patients with very severe asthma: Safety and clinical outcomes Source: International Congress 2016 – Airway stenting and ablation Year: 2016 Education of asthmatic children: Impact on the perception and on the control of the disease and usefulness of an asthma logbook Source: Annual Congress 2013 –Asthma treatment and management in children Year: 2013 Longitudinal relationship between disease specific quality of life and asthma control in children Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Which are the main determinants of quality-of-life in severe asthma? Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients Source: International Congress 2016 – Asthma management Year: 2016 Health related quality of life in asthmatic subjects after 3 months treatment with inhaled corticosteroids Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015